Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings.

Inusa BPD, Wale A, Hassan AA, Idhate T, Dogara L, Ijei I, Qin Y, Anie K, Lawson JO, Hsu L.

F1000Res. 2018 Sep 4;7. pii: F1000 Faculty Rev-1407. doi: 10.12688/f1000research.14589.1. eCollection 2018. Review.

2.

White matter integrity and processing speed in sickle cell anemia.

Stotesbury H, Kirkham FJ, Kölbel M, Balfour P, Clayden JD, Sahota S, Sakaria S, Saunders DE, Howard J, Kesse-Adu R, Inusa B, Pelidis M, Chakravorty S, Rees DC, Awogbade M, Wilkey O, Layton M, Clark CA, Kawadler JM.

Neurology. 2018 Jun 5;90(23):e2042-e2050. doi: 10.1212/WNL.0000000000005644. Epub 2018 May 11.

3.

Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.

Tewari S, Renney G, Brewin J, Gardner K, Kirkham F, Inusa B, Barrett JE, Menzel S, Thein SL, Ward M, Rees DC.

Haematologica. 2018 Jul;103(7):1136-1142. doi: 10.3324/haematol.2018.187815. Epub 2018 Mar 15.

4.

Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial.

Howard J, Slee AE, Skene S, Inusa B, Kawadler J, Downes M, Gavlak J, Koelbel M, Stotesbury H, Chorozoglou M, Tebbs S, Chakravorty S, Awogbade M, Rees DC, Gupta A, Murphy PB, Hart N, Sahota S, Nwosu C, Gwam M, Saunders D, Muthurangu V, Barber N, Ako E, Thein SL, Marshall M, Reading IC, Cheng MYE, Kirkham FJ, Liossi C.

Trials. 2018 Jan 22;19(1):55. doi: 10.1186/s13063-017-2419-0.

5.

How many people have sickle cell disease in the UK?

Dormandy E, James J, Inusa B, Rees D.

J Public Health (Oxf). 2018 Sep 1;40(3):e291-e295. doi: 10.1093/pubmed/fdx172.

PMID:
29294057
6.

Sickle Cell Disease.

Inusa B, Popoola J, Wonkam A.

N Engl J Med. 2017 Jul 20;377(3):302-303. doi: 10.1056/NEJMc1706325. No abstract available.

7.

European migration crises: The role of national hemoglobinopathy registries in improving patient access to care.

Inusa BPD, Colombatti R.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26515. Epub 2017 Mar 30. No abstract available.

PMID:
28371007
8.

Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia.

Jakubowski JA, Hoppe CC, Zhou C, Smith BE, Brown PB, Heath LE, Inusa B, Rees DC, Small DS, Gupta N, Yao S, Heeney M, Kanter J.

Thromb Haemost. 2017 Feb 28;117(3):580-588. doi: 10.1160/TH16-09-0731. Epub 2016 Dec 8.

PMID:
27929203
9.

Associations between environmental factors and hospital admissions for sickle cell disease.

Piel FB, Tewari S, Brousse V, Analitis A, Font A, Menzel S, Chakravorty S, Thein SL, Inusa B, Telfer P, de Montalembert M, Fuller GW, Katsouyanni K, Rees DC.

Haematologica. 2017 Apr;102(4):666-675. doi: 10.3324/haematol.2016.154245. Epub 2016 Dec 1.

10.

Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.

Dowling MM, Quinn CT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Dlamini N, Kirkham F, Hynan LS; PFAST Investigators.

Br J Haematol. 2017 Jan;176(2):300-308. doi: 10.1111/bjh.14391. Epub 2016 Oct 21.

11.

Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease.

Mulder N, Nembaware V, Adekile A, Anie KA, Inusa B, Brown B, Campbell A, Chinenere F, Chunda-Liyoka C, Derebail VK, Geard A, Ghedira K, Hamilton CM, Hanchard NA, Haendel M, Huggins W, Ibrahim M, Jupp S, Kamga KK, Knight-Madden J, Lopez-Sall P, Mbiyavanga M, Munube D, Nirenberg D, Nnodu O, Ofori-Acquah SF, Ohene-Frempong K, Opap KB, Panji S, Park M, Pule G, Royal C, Sangeda R, Tayo B, Treadwell M, Tshilolo L, Wonkam A.

Appl Transl Genom. 2016 Mar 15;9:23-9. doi: 10.1016/j.atg.2016.03.005. eCollection 2016 Jun.

12.

Sickle-Cell Disease in Nigerian Children: Parental Knowledge and Laboratory Results.

Obaro SK, Daniel Y, Lawson JO, Hsu WW, Dada J, Essen U, Ibrahim K, Akindele A, Brooks K, Olanipekun G, Ajose T, Stewart CE, Inusa BP.

Public Health Genomics. 2016;19(2):102-7. doi: 10.1159/000444475. Epub 2016 Mar 19.

PMID:
26991896
13.

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.

Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB, Heath LE, Jakubowski JA, Zhou C, Zamoryakhin D, Agbenyega T, Colombatti R, Hassab HM, Nduba VN, Oyieko JN, Robitaille N, Segbefia CI, Rees DC; DOVE Investigators.

N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.

14.

Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial.

Howard J, Inusa B, Liossi C, Jacob E, Murphy PB, Hart N, Gavlak J, Sahota S, Chorozoglou M, Nwosu C, Gwam M, Gupta A, Rees DC, Thein SL, Reading IC, Kirkham FJ, Cheng MY.

Trials. 2015 Aug 25;16:376. doi: 10.1186/s13063-015-0883-y.

15.

Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature.

Danaee A, Inusa B, Howard J, Robinson S.

Transfus Med Rev. 2015 Oct;29(4):220-30. doi: 10.1016/j.tmrv.2015.06.001. Epub 2015 Jun 19. Review.

PMID:
26209603
16.

Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.

Bali S, D'Cruz D, Lazaro M, Inusa BP.

BMJ Case Rep. 2015 Mar 27;2015. pii: bcr2014207579. doi: 10.1136/bcr-2014-207579.

17.

13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.

De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA.

Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23.

PMID:
25810327
18.

Cerebral microhaemorrhages secondary to fat embolus syndrome in sickle cell disease.

Alobeidi F, Inusa BP, Singh RR, U-King-Im JM.

Postgrad Med J. 2015 Jan;91(1071):55-6. doi: 10.1136/postgradmedj-2014-132984. No abstract available.

PMID:
25583740
19.

Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.

Galadanci NA, Abdullahi SU, Tabari MA, Abubakar S, Belonwu R, Salihu A, Neville K, Kirkham F, Inusa B, Shyr Y, Phillips S, Kassim AA, Jordan LC, Aliyu MH, Covert BV, DeBaun MR.

Pediatr Blood Cancer. 2015 Mar;62(3):395-401. doi: 10.1002/pbc.25289. Epub 2014 Nov 14.

20.

Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.

Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA; SIT trial investigators.

Am J Hematol. 2015 Feb;90(2):139-43. doi: 10.1002/ajh.23877.

21.

Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia.

Inusa B, Casale M, Booth C, Lucas S.

BMJ Case Rep. 2014 Oct 21;2014. pii: bcr2014205464. doi: 10.1136/bcr-2014-205464.

22.

Wheezing is common in children with sickle cell disease when compared with controls.

Galadanci NA, Liang WH, Galadanci AA, Aliyu MH, Jibir BW, Karaye IM, Inusa BP, Vermund SH, Strunk RC, DeBaun MR.

J Pediatr Hematol Oncol. 2015 Jan;37(1):16-19. doi: 10.1097/MPH.0000000000000239.

23.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

24.

Factors predicting future ACS episodes in children with sickle cell anemia.

DeBaun MR, Rodeghier M, Cohen R, Kirkham FJ, Rosen CL, Roberts I, Cooper B, Stocks J, Wilkey O, Inusa B, Warner JO, Strunk RC.

Am J Hematol. 2014 Nov;89(11):E212-7. doi: 10.1002/ajh.23819. Epub 2014 Aug 27.

25.

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

26.

Obstructive sleep apnea and sickle cell anemia.

Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, Craven DI, Gavlak JC, Wilkey O, Inusa B, Roberts I, Goodpaster RL, Malow B, Rodeghier M, Kirkham FJ.

Pediatrics. 2014 Aug;134(2):273-81. doi: 10.1542/peds.2013-4223. Epub 2014 Jul 14.

27.

Assessing the quality of life of children with sickle cell anaemia using self-, parent-proxy, and health care professional-proxy reports.

Constantinou C, Payne N, Inusa B.

Br J Health Psychol. 2015 May;20(2):290-304. doi: 10.1111/bjhp.12099. Epub 2014 Apr 23.

PMID:
24758574
28.

Dilemma in differentiating between acute osteomyelitis and bone infarction in children with sickle cell disease: the role of ultrasound.

Inusa BP, Oyewo A, Brokke F, Santhikumaran G, Jogeesvaran KH.

PLoS One. 2013 Jun 6;8(6):e65001. doi: 10.1371/journal.pone.0065001. Print 2013.

29.

Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia.

Hollocks MJ, Kok TB, Kirkham FJ, Gavlak J, Inusa BP, DeBaun MR, de Haan M.

J Int Neuropsychol Soc. 2012 Jan;18(1):168-73. doi: 10.1017/S1355617711001469. Epub 2011 Nov 24.

30.

Hydroxycarbamide use in young children with sickle-cell anaemia.

Obaro SK, Inusa B, Telfer P.

Lancet. 2011 Nov 19;378(9805):1777. doi: 10.1016/S0140-6736(11)61770-4. No abstract available.

PMID:
22098850
31.

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF.

Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17.

32.

Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.

Padayachee ST, Thomas N, Arnold AJ, Inusa B.

Pediatr Radiol. 2012 Apr;42(4):470-4. doi: 10.1007/s00247-011-2263-4. Epub 2011 Oct 15.

PMID:
22002844
33.

Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.

Daniel Y, Hill K, Inusa B, Thein SL, Howard J.

Hemoglobin. 2011;35(4):406-10. doi: 10.3109/03630269.2011.592555.

PMID:
21797706
34.

Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.

Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T.

Br J Haematol. 2011 Aug;154(3):387-97. doi: 10.1111/j.1365-2141.2011.08720.x. Epub 2011 May 19.

35.

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR.

Blood. 2011 Jan 20;117(3):772-9. doi: 10.1182/blood-2010-01-261123. Epub 2010 Oct 12.

36.

Moving young people with sickle cell disease from paediatric to adult services.

Howard J, Woodhead T, Musumadi L, Martell A, Inusa BP.

Br J Hosp Med (Lond). 2010 Jun;71(6):310-4. Review.

PMID:
20551868
37.

Pandemic influenza A (H1N1) virus infections in children with sickle cell disease.

Inusa B, Zuckerman M, Gadong N, Afif M, Arnott S, Heath P, Marais G, Robertson P, Payne H, Wilkey O, Rees DC.

Blood. 2010 Mar 18;115(11):2329-30. doi: 10.1182/blood-2009-12-260836. No abstract available.

38.

The role of religious leaders and faith organisations in haemoglobinopathies: a review.

Toni-Uebari TK, Inusa BP.

BMC Blood Disord. 2009 Aug 15;9:6. doi: 10.1186/1471-2326-9-6.

39.

Infection in sickle cell disease: a review.

Booth C, Inusa B, Obaro SK.

Int J Infect Dis. 2010 Jan;14(1):e2-e12. doi: 10.1016/j.ijid.2009.03.010. Epub 2009 Jun 3. Review.

40.

Rickets and tracheobronchomalacia.

Bangalore H, Bisht S, Inusa B.

BMJ Case Rep. 2009;2009. pii: bcr01.2009.1422. doi: 10.1136/bcr.01.2009.1422. Epub 2009 Jun 9.

41.

l-selectin gene polymorphisms and complications of sickle cell disease.

Ugochukwu CC, Okpala I, Pantelidis P, Inusa B, Ibegbulam O, Onyekwere O.

Int J Lab Hematol. 2008 Aug;30(4):312-6. doi: 10.1111/j.1751-553X.2007.00961.x.

PMID:
18665829
42.

Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.

Coleman E, Inusa B.

Clin Pediatr (Phila). 2007 Jun;46(5):386-91. Review.

PMID:
17556734
43.

A case of familial unilateral tight shoe.

Sinha R, Raman V, Inusa B.

Arch Dis Child. 2007 Jun;92(6):501. No abstract available.

44.

Rosai-Dorfman disease: a previously unreported association with sickle cell disease.

Stebbing C, van der Walt J, Ramadan G, Inusa B.

BMC Clin Pathol. 2007 Apr 2;7:3.

45.

The measurement of urinary hydroxyurea in sickle cell anaemia.

Dalton RN, Turner C, Dick M, Height SE, Awogbade M, Inusa B, Okpala I, O'Driscoll S, Thein SL, Rees DC.

Br J Haematol. 2005 Jul;130(1):138-44.

PMID:
15982356

Supplemental Content

Support Center